강스템바이오텍

217730KOSDAQ

50.4 / 100

Reference Date: 2026-09-08

Financial Score14.0 / 40

News Sentiment20.4 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Declined 6.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Kansstem Biotech, established in 2010, specializes in developing and manufacturing stem cell therapies, with core businesses in stem cell treatments and cosmetics. The stem cell division focuses on therapies for conditions like atopic dermatitis and rheumatoid arthritis, while the cosmetics division sells stem cell-derived products through online channels. The company also develops new drugs based on exosome technology for wound healing and hair loss.

Number of Employees

172people

Average Salary

57.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

3.03Industry Average 1.200.0Point

2.5x industry avg (risky)

ROE

-18.65Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

5.98Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20252.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼46.5% (2-year basis)

Operating Profit Growth Rate

2.0 / 3

Avg ▲7.9% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -29.2% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 81.7

Positive
강스템바이오텍 "빅파마와 공동평가연구 계약"
강스템바이오텍이 글로벌 빅파마와의 협력으로 피부 면역 질환 연구에 대한 공동평가계약을 체결하여 기술적 우위와 시장 진출 가능성을 높였다.
Positive
강경선 강스템바이오텍 CSO, 혈관 갖춘 '인공 간' 구현…"효과 확인...
강스템바이오텍의 연구진이 iPSC 기반 혈관화 인공 간 개발로 말기 간질환 환자 치료 접근성 향상에 기여할 것으로 기대됩니다.
Positive
“2b상 필수 아냐”…강스템바이오텍, 임상 속전속결 노림수 먹힐까
강스템바이오텍의 임상 진행 속도가 가속화될 가능성이 높아져 긍정적인 시장 반응을 기대할 수 있다.

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 2,225Won52-week high 4,61552-week low 1,361

1-month return2.0Point

1m -6.90% (slight drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-13